" class="no-js "lang="en-US"> Cancer52 - Medtech Alert
Tuesday, August 05, 2025
Cancer52 | Pharmtech Focus

Cancer52

About Cancer52

Cancer52

WHO WE ARE Cancer52 represents numerous organisations united in improving the future for everyone affected by rare and less common cancers, which account for more than half all cancer deaths in the UK. WHY US? We are: – a multi stakeholder coalition organisation that engages continually with its members to ensure our policies are member driven We have: – the ongoing authority to speak on behalf of our members – unparalleled expertise from individuals within our membership – present and influence beyond the UK, particularly in Europe OUR VISION Become the ‘go to’ organisation of choice for rare and less common cancers for all stakeholders OUR AIMS We strive to reduce deaths in and improve the quality of life for people with rare and less common cancers – ensuring an equitable share of attention, investment and voice – improving equity of treatment and supportive services – stimulating and encouraging research – engaging with members and all relevant stakeholders to share expertise and improve outcomes

Related Story

One Million Checks Delivered By NHS ‘One Stop Shops’

June 6 2022

NHS ‘one stop shops’ have delivered over one million checks and tests since the rollout […]